CDX COM INC
8-K, EX-2.1, 2000-12-06
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: CDX COM INC, 8-K, 2000-12-06
Next: CDX COM INC, 8-K, EX-2.2, 2000-12-06



Gentlemen:

      This  letter  shall set forth our  understanding  regarding  the letter of
intent  dated as of October 19, 2000 (the "LOI")  between  Tampa Bay  Financial,
Inc. ("TBF") and CDX Corporation ("CDX"). As we discussed, CDX has not been able
to fulfill certain of the conditions of the LOI,  including  without  limitation
the  requirement  of Section 3 thereof  that the 10-K be filed prior to November
15, 2000.  However,  that 10-K was filed on November 17, 2000, and the September
30 10-Q  shall be filed on or before  November  21,  2000.  Notwithstanding  the
foregoing, and in light of certain additional circumstances of which the parties
have  become  aware,  TBF is willing to go forward  with a modified  transaction
along the following lines:

     1. Immediately upon execution of this letter agreement, and upon the filing
of the SEC reports necessary to make CDX current in its filings, the undersigned
shareholders  of CDX (the "Schein  Group") will transfer to TBF or its designees
3,523,733  shares  of  common  stock of CDX,  which  they  represent  constitute
approximately  67% of the  4,888,094  then-outstanding  shares of CDX stock.  In
consideration  of such  transfer,  TBF or its  designees  will deposit in escrow
$100,000,  which will be released to the selling  shareholders  upon  compliance
with all other  provisions  of this letter  agreement.  The Escrow  Agreement is
attached hereto.

     2. TBF  understands  that CDX is in the process of  entering  into an asset
purchase  agreement  with  Cyber  Diagnostics,  Inc.  ("CDI"),  a  Rhode  Island
corporation  wholly owned by the Schein  Group,  to acquire all of the assets of
CDX in exchange  for the  assumption  by CDI of all of CDX's  liabilities.  That
transfer  shall occur on or before  November 22,  2000.  Under the terms of that
asset purchase agreement,  CDX shall be allowed to use the name "CDX" and/or CDX
SPIRO 850 CDX 50, CDX BIOSPONSE,  and CDX PIOPAIL in connection with the sale of
its  computerized  pulmonary  diagnostic  equipment and its  bio-hazard  control
products. In the event that CDX decides to change its name, CDX shall assign all
its  rights to said "CDX" name to CDI.  After  that  closing,  CDX shall have no
liabilities.

     3. The parties will take such action as is necessary to modify the Board of
Directors  of CDX,  resulting  in the  removal  from  office of all the  current
directors and their replacement with designees of TBF as of November 21, 2000.

     4. CDX will proceed to amend its articles of incorporation to authorize 500
million shares of common stock.

     5. Upon  approval of such  amendment,  in  consideration  of past  services
rendered, CDX will issue to one or more of the Schein Group 7,111,906


                                       1
<PAGE>



shares of common stock pursuant to a registration statement on Form S-8. Of such
shares, 6,511,906 will immediately be transferred to the purchasing shareholders
hereunder.  At such time, the $100,000  escrowed amount described in paragraph 1
above,  together  with an  additional  $162,500  will be disbursed to the Schein
Group by the Escrow Agent.

     6. The  amount  disbursed  in  connection  with this  transaction  shall be
reduced  by the  Schein  Group's  share  of the  fees in  connection  with  this
transaction  of Thomas P.  McNamara,  P.A.,  which fees shall not exceed $5,000.
Except for that fee, TBF agrees to be responsible for all costs  associated with
the TBF  acquisition  of control of CDX  (including  all  amounts  due to Nevado
Ltd.).

     7.  The  Schein  Group  hereby  releases  CDX  from  any  and  all  further
obligations to them, whether as employees,  officers, directors, option holders,
warrant holders or in any other capacity.

All notices under this LOI shall be sent the following parties:

If to TBF:  `                       Tampa Bay Financial, Inc.
                                    355 Interstate Blvd.
                                    Sarasota, FL 34240
                                    Attn:  Mr. Carl Smith
                                    941/923-1949; 941/921-2821 (fax)
                                    [email protected]

With a copy to:                     Thomas P. McNamara, Esq.
                                    Thomas P. McNamara, P.A.
                                    2909 Bay to Bay Blvd., Suite 309
                                    Tampa, Florida  33629
                                    813-837-0727
                                    813-837-1532 fax
                                    [email protected]

If to Company or the                CDX Corporation
Exhibit B Shareholders:             One Richmond Square
                                    Providence, RI 02906
                                    Attn:  Harold I. Schein
                                    401/521-3000; 401/751-3940 (fax)

With a copy to:                     Brendan P. Smith, Esq.
                                    Brendan P. Smith, P.C.
                                    2 Richmond Square, Suite 100
                                    Providence, RI 02906
                                    [email protected]



                                       2
<PAGE>


      If you are in agreement with this arrangement, please indicate your accep-
tance by signing below.

                                    Sincerely,

                                    TAMPA BAY FINANCIAL, INC.


                                    By:/s/ Carl Smith______________________
                                         Carl Smith,
                                          Authorized Representative

ACCEPTED THIS ___
DAY OF NOVEMBER, 2000:

/s/Harold I. Schein
--------------------
Harold I. Schein

/s/Michael Schein
--------------------
Michael Schein

/s/Philip D. Schein
--------------------
Philip D. Schein


                                       3
<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission